Back to search

Article

Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect Comparisons

2023-09-11

Abstract excerpt

In Philadelphia chromosome positive B-cell (Ph+) acute lymphoblastic leukemia (LLA), growing evidence has ac-cumulated about the efficacy of low-intensity and chemo-free regimens. Our objective was to analyze all recent trials evaluating these treatments and to compare them in terms of efficacy. We applied the Shiny method, an artificial intelligence technique, to analyze Kaplan-Meier curves and reconstruct patien...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
59d457fb-8035-57cc-bb1b-136ccf18d92b
DOI
10.20944/preprints202309.0619.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect ComparisonsDOI 10.20944/preprints202309.0619.v1
Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect ComparisonsSemantic proximity
Pirtobrutinib for First-Line Chronic Lymphocytic Leukemia: A Non-Anchored Indirect Comparison Using Reconstructed Patient-Level DataSemantic proximity
Survival in Patients With Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New TreatmentsSemantic proximity
How I treat Philadelphia chromosome–positive acute lymphoblastic leukemiaSemantic proximity
Treatment of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia in Adults: A Broader Range of Options, Improved Outcomes, and More Therapeutic DilemmasSemantic proximity
The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute lymphoblastic leukemiaSemantic proximity
How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia.Semantic proximity
How I treat Philadelphia chromosome–like acute lymphoblastic leukemia in children, adolescents, and young adultsSemantic proximity
Select a neighboring publication to make it the new centre.